Itrin en es it fr

Itrin Brand names, Itrin Analogs

Itrin Brand Names Mixture

  • No information avaliable

Itrin Chemical_Formula


Itrin RX_link

Itrin fda sheet

Itrin FDA

Itrin msds (material safety sheet)

Itrin Synthesis Reference

M. Winn et al., U.S. Pat. 4,026,894 (1977)

Itrin Molecular Weight

387.433 g/mol

Itrin Melting Point

273 oC

Itrin H2O Solubility


Itrin State


Itrin LogP


Itrin Dosage Forms


Itrin Indication

For the treatment of symptomatic benign prostatic hyperplasia (BPH) and also for hypertension.

Itrin Pharmacology

Terazosin, classified as a quinazoline, is similar to doxazosin and prazosin. As an alpha-adrenergic blocking agent, terazosin is used to treat hypertension and benign prostatic hypertrophy (BPH). Terazosin produces vasodilation and reduces peripheral resistance but in general has slight effect on cardiac output. Antihypertensive effect with chronic dosing is usually not accompanied by reflex tachycardia.

Itrin Absorption

Essentially completely absorbed in man (90% bioavailability).

Itrin side effects and Toxicity

LD50=259.3mg/kg (i.v. in mice)

Itrin Patient Information

Itrin Organisms Affected

Humans and other mammals